Podcasts about High Times

Episode summary Joe and Mary dive into how platform censorship and shifting algorithms have reshaped psychedelic media, why DoubleBlind moved to a “newsletter-first” model, and what that's revealed about true audience engagement. They reflect on the post-2024 MDMA decision headwinds, state-level policy moves (wins and losses), and how funding, politics, and culture continue to reconfigure the field. They also explore alternatives to alcohol, chronic pain research, reciprocity around iboga/ibogaine, and lessons from PS25 (MAPS' Psychedelic Science 2025). Highlights & themes From platforms to inboxes: Social and search suppression (IG/FB/Google) throttled harm-reduction journalism; DoubleBlind's pivot to email dramatically improved reach and engagement. Post-MDMA decision reality: Investment cooled; Mary frames it as painful but necessary growth—an ecosystem “airing out” rather than a catastrophic pop. Policy pulse: Mixed year—some state measures stalled (e.g., MA), others advanced (e.g., NM; ongoing Colorado process). Rescheduling cannabis may add complexity more than clarity. Censorship paradox: Suppressing education makes use less safe; independent outlets need community support to keep harm-reduction info visible. Chronic pain & long COVID: Emerging overlaps and training efforts (e.g., Psychedelics & Pain communities) point beyond a psychiatry-only frame. Alcohol alternatives: Low-dose or occasional psychedelic use can shift habits for some; Mary stresses individual context and support beyond any single substance. Reciprocity & iboga: Rising interest (including from right-leaning funders) must include Indigenous consultation and fair benefit-sharing; pace of capitalism vs. community care is an active tension. PS25 field notes: Smaller, more manageable vibe than 2023; fewer “gold-rush” expectations; in-person dialogue beats online flame wars. Notable mentions DoubleBlind: Newsletter-first publishing; nurturing new writers and reported stories. Psychedelics & Pain Association / Clusterbusters: Community-driven models informing care and research (cluster headache protocols history). Books & media: Body Autonomy (Synergetic Press anthology); Joanna Kempner's work on cluster headaches - Psychedelic Outlaws; Lucy Walker's forthcoming iboga film. Compounds to watch: LSD (under-studied relative to MDMA), 2C-B, 5-MeO-DMT (synthetic focus), and broader Shulgin-inspired families.   Mary Carreon: [00:00:00] Okay, I'm gonna send it to my dad because he wants to know. Here Joe Moore: we go. Yeah, send it over. So, hi everybody. We're live Joe here with Mary Anne, how you doing today? Mary Carreon: I'm great Joe. How are you? Joe Moore: Lovely. I actually never asked you how to pronounce your last name does say it right? Mary Carreon: Yes, you did. You said it perfectly Joe Moore: lovely. Joe Moore: Um, great. So it's been a bit, um, we are streaming on LinkedIn, YouTube, Twitch X and Kick, I guess. Yeah. Kick meta. Meta doesn't let me play anymore. Um, Mary Carreon: you're in forever. Timeout. I got it. I got it. Yeah. Joe Moore: Yeah. I think they found a post the other day from 2017. They didn't like, I'm like, oh cool. Like neat, you Mary Carreon: know, you know. Mary Carreon: Yeah. That happened to me recently, actually. Uh, I had a post taken down from 2018 about, uh, mushroom gummies and yeah, it was taken down and I have strikes on my account now. So Joe Moore: Do you get the thing where they ask you if you're okay? Mary Carreon: Yes, with, but like with my searches though, [00:01:00] like if I search something or, or someone's account that has, uh, like mushroom or psychedelic or LSD or something in it, they'll be like, mm-hmm are you okay? Mary Carreon: And then it recommends getting help. So Joe Moore: it's like, to be fair, I don't know if I'm okay, but Yeah, you're like, probably not. I don't really want your help. Meta. Yeah. Mary Carreon: You're like, I actually do need help, but not from you. Thanks. Yeah, Joe Moore: yeah, yeah. Mary Carreon: So not from the techno fascists. Joe Moore: Oh, good lord. Yeah. Uh, we'll go there. Joe Moore: I'm sure. Mary Carreon: I know. I just like really dove right there. Sorry. Yeah. All right, so let's, Joe Moore: um, before we go, let's give people like a bit of, you know, high kicks on, on who is Mary, where you working these days and what are you doing? Mary Carreon: Yeah, thank you. My name is Mary Carryon and I am forever and first and foremost a journalist. Mary Carreon: I have been covering, I say the plant legalization spaces for the past decade. It's, it's been nine and a half years. Uh, on January 3rd it will be [00:02:00] 10 years. And I got my start covering cannabis, uh, at OC Weekly. And from there went to High Times, and from there went to Mary Jane, worked for Snoop Dogg. And then, uh, I am now. Mary Carreon: Double blind. And I have become recently, as of this year, the editor in chief of Double Blind, and that's where I have been currently sinking my teeth into everything. So currently, you know, at this moment I'm an editor and I am basically also a curator. So, and, and somebody who is a, uh, I guess an observer of this space more than anything these days. Mary Carreon: Um, I'm not really reporting in the same way that I was. Um, but still I am helping many journalists tell stories and, uh, I feel kind of like a story midwife in many ways. Just like helping people produce stories and get the, get the quotes, get the angles that need to be discussed, get the sentences structures right, and, um, uh, helping [00:03:00] sometimes in a visionary kind of, uh, mindset. Mary Carreon: So yeah, that's what I'm doing these days. Joe Moore: Oh, there it is. Oh, there you are. Love that. And um, you know, it's important to have, um, editors who kind of really get it from a lot of different angles. I love that we have a lot of alignment on this kind of, and the drug war thing and kind of let's, uh, hopefully start developing systems that are for people. Joe Moore: Yeah, absolutely. If you wanna just say that. Yeah, absolutely. Mary Carreon: Yeah, absolutely. Joe Moore: So, um, yeah, I almost 10 years in January. That's great. We um, it's so crazy that it's been that long. I think we just turned nine and a half, so we're maybe just a few, a few months shorter than your I love it. Plant medicine reporting career. Joe Moore: That's great. I love it. Um, yeah, so I think. I think one of the first times we chatted, [00:04:00] um, I think you were doing a piece about two cb Do you, do you have any recollection of doing a piece on two cb? Mary Carreon: I do, yes. Yes. Wait, I also remember hitting you up during an Instagram live and I was like, are you guys taking any writers? Mary Carreon: And you guys were like writers, I mean, maybe depending on the writer. Joe Moore: And I was like, I was like, I dunno how that works. Mary Carreon: Like me. Yeah. Joe Moore: Yeah. It was fun. It was fun to work with people like yourself and like get pieces out there. And eventually we had an awesome editor for a bit and that was, that was really cool to be able to like support young startup writers who have a lot of opinions and a lot of things to point out. Joe Moore: There's so much happening. Um, there was so much fraud in like wave one. Of kind of the psychedelic investment hype. There's still some, but it's lesser. Um, and it's really a fascinating space still. Like changing lives, changing not just lives, right? Like our [00:05:00] perspective towards nearly everything, right? Joe Moore: Yeah. Mary Carreon: Yes, absolutely. Absolutely. I mean, it's interesting because the space has matured. It's evolved. It's different than it was even, what a, I mean, definitely nine years ago, but even five years ago, even four years ago, even last year, things are different. The landscape is different than it was a year ago. Mary Carreon: And I, it's, it's interesting to see the politics of things. It's interesting to see who has money these days given like how hard it is just to kind of survive in this space. And it's interesting just to. Bear witness to all of this going down because it really is a once in a lifetime thing. Nothing is gonna look the same as it does now, as it, uh, then it will like in a, in a year from now or anything. Mary Carreon: So it's really, yeah. It's interesting to take account of all of this Joe Moore: That's so real. Uh, maybe a little [00:06:00] too real, like it's serious because like with everything that's going on from, um, you know, governance, governments, ai Yes. Drug policy shifts. Drug tech shifts, yes. There's so much interesting movement. Um, yes. Joe Moore: You, you know, you, you kind of called it out and I think it's really actually worth discussing here since we're both here on the air together, like this idea that the psychedelic market, not idea, the lived experience of the psychedelic market having shifted substantially. And I, I, I think there's a lot of causes. Joe Moore: But I've never had the opportunity to really chat with you about this kind of like interesting downturn in money flowing into the space. Mm-hmm. Have you thought about it? Like what might the causes be? I'm sure you have. Mary Carreon: Yeah. Yeah, I have. Yeah. I've thought about it. I mean, it's hard. Well, I don't know. I am really not trying to point fingers and that's not what I'm [00:07:00] trying to do here. Mary Carreon: But I mean, I think a lot of people were really hopeful that the FDA decision last June, not last June, the previous June, a year ago, 2024, June was going to open the floodgates in terms of funding, in terms of, um. In terms of mostly funding, but also just greater opportunities for the space and, uh, greater legitimacy granted to the psychedelic medicine space. Mary Carreon: Mm. And for those who might not know what I'm talking about, I'm talking about the, uh, FDA decision to reject, uh, MDMA assisted therapy and, um, that whole, that whole thing that happened, I'm sure if it, you didn't even have to really understand what was going on in order to get wind of that wild situation. Mary Carreon: Um, so, so maybe, yeah. You probably know what I'm talking about, but I, I do think that that had a great impact on this space. Do I think it was detrimental to this space? [00:08:00] I don't think so. We are in a growth spurt, you know, like we are growing and growing pains happen when you are evolving and changing and learning and figuring out the way forward. Mary Carreon: So I think it was kind of a natural process for all of this and. If things had gone forward like while, yeah, there probably would be more money, there would be greater opportunity in this space for people wanting to get in and get jobs and make a living and have a life for themselves in this, in this world. Mary Carreon: I don't know if it was, I don't know if it would necessarily be for the betterment of the space in general for the long term. I think that we do have to go through challenges in order for the best case scenarios to play out in the future, even though that's difficult to say now because so many of us are struggling. Mary Carreon: So, but I, but I have hope and, and that statement is coming from a place of hope for the future of this space and this culture. Joe Moore: Yeah. It's, um, I'm with [00:09:00] you. Like we have to see boom bust cycles. We have to see growth and contraction just like natural ecosystems do. Mary Carreon: Absolutely, absolutely. It has to be that way. Mary Carreon: And if it's not that way, then ifs, if. It's, it like what forms in place of that is a big bubble or like a, a hot air balloon that's inevitably going to pop, which, like, we are kind of experiencing that. But I think that the, I think that the, um, the, the air letting out of the balloon right now is a much softer experience than it would be if everything was just like a green light all the way forward, if that makes sense. Mary Carreon: So, Joe Moore: right. And there's, there's so many factors. Like I'm, I'm thinking about, uh, metas censorship like we were talking about before. Yes. Other big tech censorship, right? Mm-hmm. SEO shifts. Mary Carreon: Oh. Um, yes, absolutely. Also, uh, there were some pretty major initiatives on the state level that did not pass also this past year that really would've also kind of [00:10:00] helped the landscape a little bit. Mary Carreon: Um. In terms of creating jobs, in terms of creating opportunities for funding, in terms of having more, uh, like the perception of safer money flow into the space and that, you know, those, those things didn't happen. For instance, the measure for in Massachusetts that didn't go through and just, you know, other things that didn't happen. Mary Carreon: However, there have been really good things too, in terms of, uh, legalization or various forms of legalization, and that's in New Mexico, so we can't, you know, forget that there, and we also can't forget just the movement happening in Colorado. So there are really great things happening and the, the movement is still moving forward. Mary Carreon: Everything is still going. It's just a little more difficult than maybe it could have been Joe Moore: right. Yeah. Amen. Amen. Yes. But also, we Mary Carreon: can't forget this censorship thing. The censorship thing is a horse shit. Sorry. I'm not sure if I'm allowed to cuss, but it is, [00:11:00] but it is Joe Moore: calling it out and it's important to say this stuff. Joe Moore: And you know, folks, if you want to support independent media, please consider supporting Doubleblind and psychedelics today. From a media perspective, absolutely. We wanna wanna put as much out as we can. Yes. The more supporters we have, the more we can help all of you understand what's happening and yes. Joe Moore: Getting you to stay safer. Mary Carreon: Yeah, absolutely. And that's the whole difficulty with the censorship is that psychedelics today, and Doubleblind for instance, but also Lucid News, also other, uh, other influencers, other creators in the space, they like. What all of us are doing is putting out information that is ultimately creating a safer user experience. Mary Carreon: And so with the censorship, we are not able to do so anymore, which creates actually a lot of danger. So. Yeah, it's, it's difficult. The censorship is difficult, and if you are somebody who posts about psychedelics, I know that you know this and I am preaching to the choir. Joe Moore: Yeah. So can you talk a [00:12:00] little bit about you all at Double Blind made a major shift in the last number of months towards, uh, kind of not necessarily putting everything out there and, and kind of like, um, actually I don't even know the language you use. Joe Moore: What's the, what's the language you use for the kind of model shift you took on? Mary Carreon: Yeah, I mean, it's great. It's been a wild shift. It's been a wild shift. Um, what we are currently doing is we went to a newsletter first model, which instead of just posting onto a website for everyone to see, and then, um, you know, hopefully getting SEO hits and also posting on their, then posting those stories onto Instagram and Facebook and Twitter, and hoping to get traffic through social media. Mary Carreon: Uh, we decided that that was no longer working for us because it wasn't, um, because the censorship is so bad on, on social media, like on Instagram, for instance, and Facebook and Twitter, well, less on Twitter, [00:13:00] but still, nonetheless on social media, the censorship is so bad. And also the censorship exists on Google. Mary Carreon: When you Google search how to take mushrooms, double blinds is not even on. You know, our guide is not on the first page. It's like, you know, way the heck, way the heck down there. Maybe page 2, 3, 4, 5. I don't know. But, um, the issue, the issue with that, or, or the reason why rather that it's that way is because Google is prioritizing, um, like rehabilitation centers for this information. Mary Carreon: And also they are prioritizing, uh, medical information. So, like WebMD for instance. And all of these organizations that Google is now prioritizing are u are, are, are, are organizations that see psychedelic use through the lens of addiction or through drug drug abuse. So [00:14:00] again, you know, I don't know, take it for how you want to, I'm not gonna say, I'm not gonna tell anybody like what is the right way to use their substances or whatever. Mary Carreon: However, it's really important to have the proper harm reduction resources and tools available. Uh, just readily available, not five pages down on a Google search. So anyways, all of that said double blind was our traffic was way down. And it was looking very bleak for a while. Just we were getting kicked off of Instagram. Mary Carreon: We weren't getting any traffic from social media onto our website, onto our stories. It was a, it was a vicious kind of cycle downward, and it wasn't really working. And there was a moment there where Doubleblind almost shut down as a result of these numbers because there's a, like you, a media company cannot sustain itself on really low page views as a result. Mary Carreon: So what we [00:15:00] decided to do was go to a newsletter first model, which relies on our email list. And basically we are sending out newsletters three days a week of new original content, mostly, uh, sometimes on Wednesdays we repost an SEO story or something like that. Um, to just to engage our audience and to work with our audience that way, and to like to actually engage our audience. Mary Carreon: I cannot emphasize that enough because on Instagram and on Facebook, we were only reaching like, I don't know, not that many people, like not that many people at all. And all of that really became obvious as soon as we started sending out to our email list. And as soon as we did that, it was wild. How many, how many views to the website and also how many just open like our open rate and our click through rate were showing how our audience was reacting to our content. Mary Carreon: In other words. [00:16:00] Social media was not a good, in, like, was not a good indicator of how our content was being received at all because people kind of weren't even receiving it. So going to the newsletter first model proved to be very beneficial for us and our numbers. And also just reaching our freaking audience, which we were barely doing, I guess, on social media, which is, which is wild, you know, for, for a, an account that has a lot of followers, I forget at this exact moment, but we have a ton, double blind, has a ton of followers on, on Instagram. Mary Carreon: We were, we, we get like 500 likes or, you know, maybe like. I don't know. If you're not looking at likes and you're looking at views, like sometimes we get like 16 K views, which, you know, seems good, but also compared to the amount of followers who follow us, it's like not really that great. And we're never reaching new, like a new audience. Mary Carreon: We're always reaching the same audience too, [00:17:00] which is interesting because even with our news, with our, with our email list, we are still reaching new people, which is, which says just how much more fluid that space is. Mm-hmm. And it's because it's, because censorship does not at least yet exist in our inboxes. Mary Carreon: And so therefore email is kind of like the underground, if you will, for this kind of content and this type of material journalism, et cetera. So, so yeah. So it, it, it has been a massive shift. It is required a lot of changes over at double blind. Everything has been very intense and crazy, but it has been absolutely worth it, and it's really exciting that we're still here. Mary Carreon: I'm so grateful that Double-Blind is still around, that we are still able to tell stories and that we are still able to work with writers and nurture writers and nurture the storytelling in this space because it needs to evolve just the same way that the industry and the [00:18:00] culture and everything else is evolving. Joe Moore: Yeah, I think, I think you're spot on like the, when I watch our Instagram account, like, um, I haven't seen the number change from 107 K for two years. Mary Carreon: Absolutely. Same. And, um, same. Joe Moore: Yeah. And you know, I think, I think there's certain kinds of content that could do fine. I think, uh, psychedelic attorney, Robert Rush put up a comment, um, in response to Jack Coline's account getting taken down, um, that had some good analysis, um. Joe Moore: Of the situation. Go ahead. You had No, Mary Carreon: no, I'm just like, you know, I can't, when, when journalists are getting kicked off of these, of these platforms for their stories, for their reported stories, that's like, that is a massive red flag. And that's all I have to say. I mean, we could go into more, more details on that, but that is a [00:19:00] huge red flag. Joe Moore: Mm-hmm. Yeah. Um, for sure. The, I, yeah. And like I'm sure he'll get it back. I'm sure that's not for good, but I think he did. Okay, great. Mary Carreon: I think he did. Yeah. Yeah, I think he did. Joe Moore: Yeah. So thank you. Shout out to Jack. Yeah, thanks Jack. Um, and I think, you know, there's, there's no one with that kind of energy out there. Joe Moore: Um, and I'm excited to see what happens over time with him. Yeah. How he'll unfold. Absolutely unfold. Oh yeah. It's like, um. Crushing the beat. Mary Carreon: Oh yeah, absolutely. Especially the political, the political beat. Like, there's no, there's few people who are really tackling that specific sector, which is like mm-hmm. Mary Carreon: So exciting for a journalist. Joe Moore: Yeah. Um, so model shifting, like we all have to like, adapt in new ways. Kyle and I are still trying to figure out what we're gonna do. Like maybe it is newsletter first. Like I, I realized that I hadn't been writing for [00:20:00] years, which is problematic, um, in that like, I have a lot of things to say. Mary Carreon: Totally. Joe Moore: And nobody got to hear it. Um, so I started a substack, which I had complicated feelings about honestly. 'cause it's just another. Rich person's platform that I'm, you know, helping them get Andreessen money or whatever. And, you know, so I'm gonna play lightly there, but I will post here and there. Um, I'm just trying to figure it all out, you know, like I've put up a couple articles like this GLP one and Mushrooms article. Mary Carreon: I saw that. I saw that. Really? And honestly, that's a really, like, it's so weird, but I don't, like, it's such a weird little thing that's happening in the space. I wonder, yeah, I wonder, I wonder how that is going to evolve. It's um, you know, a lot of people, I, I briefly kind of wrote about, um, psychedelics and the GLP, is that what it is? Mary Carreon: GLP one. Joe Moore: GLP one. Say Ozempic. Yeah, just, yeah, Ozempic. Yeah, exactly. Mary Carreon: Yeah, exactly. I wrote about [00:21:00] that briefly last year and there were a bunch of people like obviously horrified, which it is kind of horrifying, but also there's a bunch of people who believe that it is extremely cutting edge, which it also is. Mary Carreon: So it's really interesting, really fascinating. Joe Moore: Yeah. Um, I remember Bernie Sanders saying like, if this drug gets as much traction as it needs to, it will bankrupt Medicaid. I guess that's not really a problem anymore. Um, but, but, uh, but so like naming it real quick, like it changed the way we had to digest things, therefore, like mushrooms get digested differently and, um, some people don't respond in the expected ways. Joe Moore: And then there was some follow up, oh, we, in the regulated model, we just do lemon tech. And then I was like, is that legal in the regulated model? And I, I don't know the answer still. Mm-hmm. Like there was a couple things, you know, if users know to do it, you know, I don't, I don't totally understand the regulated model's so strange in Oregon, Colorado, that like, we really need a couple lawyers opinions. Joe Moore: Right. I think Mary Carreon: yes, of course Joe Moore: the lawyers just gave it a [00:22:00] thumbs up. They didn't even comment on the post, which is, laughs: thanks guys. Um, Joe Moore: but you know, laughs: yeah. You're like, thank you. Joe Moore: Thanks and diversity of opinions. So yeah, there's that. And like GLP ones are so interesting in that they're, one friend reached out and said she's using it in a microdose format for chronic neuroinflammation, which I had never heard of before. Joe Moore: Whoa. And um, I think, you know, articles like that, my intent was to just say, Hey, researchers yet another thing to look at. Like, there's no end to what we need to be looking at. Abso Mary Carreon: Oh, absolutely, absolutely. You know, reporting on this space actually taught me that there's so much just in general that isn't being researched, whether that's in this space, but also beyond and how, um, yeah, just how behind, actually, maybe not, maybe behind isn't the right word, but it kind of feels from my novice and from my novice place in the, in the world and [00:23:00] understanding research, it's. Mary Carreon: Hard for me to see it as anything, but being behind in the research that we all really need, that's really going to benefit humanity. But also, you know, I get that it's because of funding and politics and whatever, whatever, you know, we can go on for days on all of that. Joe Moore: What's the real reason? What's the real reason? Joe Moore: Well, drug war. Mary Carreon: Yeah. Well, yeah, definitely the drug war. Nixon. Yeah. Yes, yes, definitely the drug war. Yeah. I mean, and just the fact that even all of the drug research that happens is, again, through the lens of addiction and drug abuse, so Joe Moore: mm-hmm. Hard to right. Yeah. Um, like ni a is obviously really ridiculous and, and the way they approach this stuff, and Carl Hart illustrates that well, and, Mary Carreon: oh man, yes, he does. Joe Moore: Like, I think Fadiman's lab in Palo Alto got shut down, like 67, 66 or 67, and like that's, you know, that was one of the later ones, Mary Carreon: right? And, Joe Moore: and like, Mary Carreon: and here we are. Joe Moore: The amount of suffering that could have been alleviated if we [00:24:00] had not done this is. Incalculable. Um, yes. Yes. Yeah. Mary Carreon: I mean the, yeah, it's hard to say exactly how specifically it would be different, but it's difficult to also not think that the fentanyl crisis and the opioid addiction rate and situation that is currently like plaguing the, the world, but particularly the United States, it's hard to think that it wouldn't be, like, it wouldn't be a different scenario altogether. Joe Moore: Right, right. Absolutely. Um, and it's, um, it's interesting to speculate about, right? Like Yeah. Yes. Where would we be? And Mary Carreon: I know, I know, I know, I know it is speculation. Absolutely. But it's like hard, as I said, it's hard not to think that things would be different. Joe Moore: Right. Right. Um, I like, there's two kind of quotes, like, um, not, this one's not really a quote. Joe Moore: Like, we haven't really had a [00:25:00] blockbuster psychiatric med since Prozac, and I think that was in the eighties or early nineties, which is terrifying. And then, um, I think this guy's name is James Hillman. He is kinda like a Jungian, um, educator and I think the title of one of his books is, we're a hundred Years Into Psychotherapy and the World is Still a Mess. Joe Moore: And I think like those two things are like, okay, so two different very white people approaches didn't go very far. Yes. Um, yes and laughs: mm-hmm. Joe Moore: Thankfully, I think a lot of people are seeing that. Mm-hmm. Um, finally and kind of putting energy into different ways. Um, Mary Carreon: yeah. Absolutely. I think, yeah, I mean, we need to be exploring the other options at this point because what is currently happening isn't working on many fronts, but including in terms of mental health especially. Mary Carreon: So mm-hmm. We gotta get going. Right? We [00:26:00] gotta get moving. Geez. Joe Moore: Have you all, have you all seen much of the information around chronic pain treatments? Like I'm, I'm a founding board member with the Psychedelics and Pain Association, which has a really fun project. Oh, that's interesting. Mary Carreon: Um, I've seen some of the studies around that and it's endlessly fascinating for obvious, for obvious reasons. Mary Carreon: I, um, we have a writer who's been working for a long time on a story, uh, about the chronic pain that has since. Become an issue for this, for her, for the writer. Mm-hmm. Um, since she had COVID. Mm-hmm. Since, since she is just like, COVID was the onset basically of this chronic pain. And, um, there she attended a psychedelics in pain, chronic pain conference and, uh, that has pretty much like, changed her world. Mary Carreon: Um, well, in terms of just the information that's out there, not necessarily that she's painless, but it's just, you know, offering a, a brand new, a brand new road, a brand new path that is giving her, [00:27:00] um, relief on days when the pain is, uh, substantial. laughs: Yeah. Mary Carreon: So that's interesting. And a lot of people are experiencing that as well. Joe Moore: Mm-hmm. So there's, there's a really cool set of overlap between the COVID researchers, long COVID researchers and the chronic pain people. 'cause there is Yes. This new science of pain that's yes. Our group, PPA put out like a really robust kind of training, um, for clinicians and researchers and even patients to get more educated. Joe Moore: And we're, we're getting, um, kind of boostered by cluster busters and we're kind of leveraging a lot of what they've done. Mary Carreon: Wait, what is a cluster buster? Joe Moore: Oh gosh. Um, so they're a 5 0 1 C3. Okay. Started with Bob Wald. Okay. Bob Wald is a cluster headache survivor. Oh, oh, oh, Mary Carreon: okay. Got it. Got it. Yes. So they're Joe Moore: the charity that, um, has been really championing, um, cluster headache research because they found a protocol [00:28:00] with mushrooms. Joe Moore: Yes, yes, yes. To eliminate. Mm-hmm. Yeah. Um, this really great, I Mary Carreon: love that. Joe Moore: This really great book was written by a Rutgers, um, I think medical sociologist or anthropologist psychedelic. Love laughs: that. Joe Moore: Joanna Kempner. Cool. Um, and it kind of talks about the whole, um, cluster busters saga, and it was, it was pretty cool. Joe Moore: Nice. So they've been at it for about as long as maps. Um, oh wow. Maybe a little earlier. Maybe a little later. Mary Carreon: I love that. Cool. I mean, yeah, that's really great. That's really great. Joe Moore: So we're copying their playbook in a lot of ways and Cool. We about to be our own 5 0 1 C3 and, um, nice. And that should be really fun. Joe Moore: And, uh, the next conference is coming up at the end of next month if people wanna check that out. Psychedelic. Nice. Mary Carreon: Nice, nice, nice. Cool. Joe Moore: Yeah, so that, like, how I leaned into that was not only did I get a lot of help from chronic pain with psychedelics and going to Phish shows and whatever, um, you know, I, and overuse for sure helped me somehow. Joe Moore: [00:29:00] Um, God bless. Yeah. But I, I like it because it breaks us out of the psychiatry only frame for psychedelics. Mm. And starts to make space for other categories. Mm-hmm. Is one of the bigger reasons I like it. Mary Carreon: Mm-hmm. Mm-hmm. Yes. Yes. Which, like, we need to be, we need to, we, no one else is gonna do it for us. We like the people in the space who are finding new uses for these substances need to be creating those, those pathways and those new niches for people to then begin studying, et cetera, and exploring and yeah. Mary Carreon: Making, making a proper avenue for, Joe Moore: right, right. And, you know, um, I don't know that this is a Maha thing, so No, I'm going there, I guess, but like, how do we kind of face squarely America and the world's drinking problems? Not [00:30:00] knowing what we know now about alcohol, you know what I mean? And then like, what are the alternatives? Joe Moore: You know, some, some writers out there on substack are very firm that everybody needs to not do any substance. And like all psychedelics are super bad and drugs are evil, you know, famous sub stackers that I won't name. But you know, like what is the alternative? Like, I, like we have to have something beyond alcohol. Joe Moore: And I think you've found some cannabis helpful for that. Mary Carreon: Yeah, I, you know, it's, it's interesting because it's, there are, there's definitely an argument to be made for the power of these substances in helping, I don't wanna, I don't wanna say curb, but definitely reduce the symptoms of, uh, wanting to use or to drink or to consume a specific substance. Mary Carreon: There's obviously there is an argument to be made. There are, there is ano another camp of people who are kind [00:31:00] of in the, in the, in the, in the realm of using a drug to get off of a drug isn't how you do it. However, and, and I do, it depends on the individual. It depends on the individual and the, and how that person is engaging with their own addiction. Mary Carreon: I think for whether or not the substances work, like whether psychedelics work to help somebody kind of get off of alcohol or get off of cocaine or stop using opioids or, you know, et cetera. Mm-hmm. However, I think like, when the situation is so dire, we need to be trying everything. And if that means, like, if, like, you know, if you look at the studies for like smoking cessation or alcohol use, mushrooms do help, psilocybin does help with that. Mary Carreon: Mm-hmm. But, you know, there's, there's a lot of, there's a lot of things that also need to happen. There's a lot of things that also need to happen in order for those, uh, that relief to maintain and to stick and to, uh, really guide [00:32:00] somebody off of those substances. Mm-hmm. It's not just the substance itself. Joe Moore: Right. So I'm, I'm explicitly talking like recreational alternatives, right. Like how do I Yeah. On per minute, like, am Anitas becoming helpful? Yeah, yeah. Are helpful and Yeah. Yeah. I think like even, um, normal. What we might call like normal American alcohol use. Like Yeah. That's still like, quite carcinogenic and like, um, absolutely. Joe Moore: We're kind of trying to spend less as a country on cancer treatments, which I hope is true. Then how do we, how do we develop things that are, you know, not just abstinence only programs, which we know for sure aren't great. Mary Carreon: Yeah. They don't work. Yeah. I don't, it's, it's difficult. Mm-hmm. It's difficult to say. Mary Carreon: I mean mm-hmm. I don't know. Obviously I, I, well, maybe it's not obvious at all for people who don't know me, but, you know, I exist in a, I exist in, in a world where recreational use is like, it's like hard to define what recreational use is because if we are using this, if we are using mushrooms or LSD even, or MDMA, [00:33:00] you know, there are so many, there's a lot of the therapy that can happen through the use of these substances, even if we're not doing it, you know, with a blindfold on or whatever and yeah, I think like. Mary Carreon: There is a decent swap that can happen if you, if you are somebody who doesn't wanna be, you know, having like three beers a night, or if you are somebody who's like, you know, maybe not trying to have like a bottle of wine at a night or something like that, you know, because like Americans drink a lot and a lot of the way that we drink is, um, you know, like we don't see it as alcoholism. Mary Carreon: Even though it could be, it could be that's like a difficult Joe Moore: potentially subclinical, but right there. Mary Carreon: Um, yeah. Yeah. It's like, you know, it's, um, we don't see it as that because everybody, a lot of people, not everybody, but a lot of people drink like that, if that makes sense. If you know mm-hmm. If you, if you get what I'm, if you get what I'm saying. Mary Carreon: So, you know, I do think that there's a lot of benefit that, I don't [00:34:00] know, having, like a, having a mushroom, having a mushroom experience can really help. Or sometimes even like low dose, low doses of mushrooms can also really help with, like, with the. Desire to reach for a drink. Yeah, totally. And, and AMS as well. Mary Carreon: I know that that's also helping people a lot too. And again, outside of the clinical framework. Joe Moore: Yeah. I'm, a lot of people project on me that I'm just like constantly doing everything all the time and I'm, I'm the most sober I've been since high school. You know, like it's bonkers that like Yeah. Um, and you know, probably the healthiest event since high school too. Joe Moore: Yeah. But it's fa it's fascinating that like, you know, psychedelics kind of helped get here and even if it was like For sure something that didn't look like therapy. Yeah, Mary Carreon: yeah, yeah, yeah. Absolutely. Absolutely. Yeah. I, I think, I think most of us here in this space are getting projected on as to like, you know, being like what Normies would consider druggies or something, or that we are just like, you know, high all the time. Mary Carreon: Um, [00:35:00] I know that that is definitely something that I face regularly, like out in the world. Um, but, you know, I would also, I would also argue that. Uh, like mushrooms have completely altered my approach to health, my approach to mental health, and not even having to consume that, you know, that substance in order or that, you know, that fun fungi, in order for me to like tap into taking care of my mental health or approaching better, uh, food options, et cetera. Mary Carreon: It's kind of like what these, it's like how the mushrooms continue to help you even after you have taken them. Like the messages still keep coming through if you work with them in that capacity. Right. And yeah, and also same with, same with LSD too. LSD has also kind my experiences with that have also guided me towards a healthier path as well. Mary Carreon: I, I understand that maybe for some people it's not that way, but, um, for me that substance is a medicine as well, [00:36:00] or it can be. Joe Moore: Yeah. Um, so. What are, what are some things popping up these days about like US drug policy that's like getting exciting for you? Like, are you feeling feeling like a looming optimism about a, a major shift? Joe Moore: Are you kind of like cautiously optimistic with some of the weird kind of mandatory minimum stuff that's coming up or? Mary Carreon: Yeah. Yeah. I mean, I know that there was a huge, a, a pretty huge shift over at the DEA and I wish I remembered, I wish I remembered his name. The new guy who's now, I believe the head of the DEA, I don't know enough information about it to really feel a way. Mary Carreon: However, I don't think that he's necessarily going to be serving us as a community here, uh, in the psychedelic space. I, you know, I just don't think that that's something that we can ever depend on with the DEA. Uh, I also don't think that [00:37:00] the DEA is necessarily going to be. All that helpful to cannabis, like the cannabis space either. Mary Carreon: Um, I know that, that Trump keeps kind of discussing or, or dangling a carrot around the rescheduling of cannabis. Um, for, he's been, he's been, but he's doing it a lot more now. He's been talking about it more recently. Uh, he says like, in the next like couple weeks that he's going to have some kind of decision around that, allegedly. Mary Carreon: But we will see also, I'm not sure that it's going to necessarily help anybody if we reschedule two. Uh, what from schedule one to schedule th two, three, schedule three. Joe Moore: Either way it's like not that useful. Right. Exactly. Mary Carreon: Yeah. Yeah, exactly. It's, um, just going to probably cause a lot more red tape and a lot of confusion for the state rec markets. Mary Carreon: So it's like something that we, it's like only ridden with unintentional, unintentional consequences. Unintended consequences. Mm-hmm. Because no one knows how it's really going to [00:38:00] impact anything, um, if, if at all. But I don't know. It's hard, it's hard to imagine that there won't be any, uh, like more complex regulatory issues for business owners and also probably consumers as well. Joe Moore: Hmm. Yeah. This guy's name's Terry Cole. Mary Carreon: Oh, the new DEA guy. Joe Moore: Yeah. Um, I don't know much about him. Terry. Yeah. Terry, I would love to chat. Mary Carreon: Yeah. Terry, let's talk. I'm sure your people Joe Moore: are watching. Yeah. So like, just let him know. We wanna chat. Yeah. We'll come to DC and chat it out. Um, yeah. It's, um, but yeah, I, Carl Hart's solution to me makes like almost most of the sense in the world to just end the scheduling system Absolutely. Joe Moore: And start building some sort of infrastructure to keep people safe. That's clearly not what we have today. Mary Carreon: No. But building an infrastructure around the health and wellness and uh, safety of [00:39:00] people is the exact opposite system that we have currently right now. Because also the scheduling system has a lot to do with the incarceration in the United States and the criminal just, or the criminal system. Mary Carreon: So, so yeah, like we can't disentangle the two really. Joe Moore: It just started, um, I feel negligent on this. Uh, synergetic press put out a book like a year or two ago called Body Autonomy. Mm-hmm. Um, did that one come across your desk at all? Mm-hmm. No. I wish basically contributed. Oh, nice. A number of people. So it's both like, um. Joe Moore: Drug policy commentary and then like sex work commentary. Oh, nice. And it was like high level, like love that really, really incredible love that detailed science based conversations, which is not what we have around this. Like, that doesn't make me feel good. So you should go to jail kind of stuff. Or like, I'm gonna humiliate you for real though. Joe Moore: Ticket. Yeah, Mary Carreon: yeah, yeah, yeah, yeah. Oh God. Uh, when you think about it like that, it just really also shows [00:40:00] just the uh, um, the level at which religion has also kind of fundamentally infused itself into the scheduling system, but also our laws, you know, like what you just said, this like, shame-based, I'm going to embarrass you and make you into a criminal when you know actually you are a law for the most part, a law abiding citizen, with the exception of this one thing that you're doing for. Mary Carreon: A, your survival and or your, like, your feeling good, wanting to feel good addressing pain. Um, there's a large, uh, like noise coming out of the front yard of my house right now. Hold on. Just a, it doesn't sound too bad. It doesn't sound too bad. Okay. Okay, good. Not at all. Not at all. Okay. Yeah, I had Joe Moore: people working on my roof all day and somehow it worked out. Joe Moore: Oh, good. Um, yeah. Um, yeah, it's, it's fascinating and I, I've been coming around like, I, I identify as politically confused, [00:41:00] um, and I feel like it's the most honest way I can be. Um, Mary Carreon: I am also politically confused these days, impossible to align with any, uh, party or group currently in existence at this exact juncture in American history. Joe Moore: I can't find any that I want to throw my dice in with. Nah. This idea of like fucking way being. Like what is the most humane way to do government as a way it's been put to me recently. And that's interesting. So it comes down to like coercion, are we caring for people, things like that. And um, I don't think we're doing it in a super humane way right now. Mary Carreon: Um, we, yeah, I am pretty sure that even if there was, I mean, I think that even if we looked at the data, the data would support that we are not doing it in a humane way. Joe Moore: So Mary Carreon: unfortunately, and Joe Moore: you know, this whole tech thing, like the tech oligarch thing, you kind of dropped at the beginning and I think it's worth bringing that back because we're, we're on all [00:42:00] these tech platforms. Joe Moore: Like that's kind of like how we're transmitting it to people who are participating in these other platforms and like, you know, it's not all meta. I did turn on my personal Facebook, so everybody's watching it there. I hope. Um, see if that count gets, Mary Carreon: um, Joe Moore: but you know, this idea that a certain number of private corporations kind of control. Joe Moore: A huge portion of rhetoric. Um, and you know, I think we probably got Whiffs of this when Bezos bought Washington Post and then Yes. You know, Musk with X and like yes. You know, is this kind of a bunch of people who don't necessarily care about this topic and the way we do, and they're like in larger topics too about humane government and like, you know, moving things in good directions. Joe Moore: Um, I don't know, thoughts on that rift there as it relates to anything you, wherever you wanna go. Yeah. Mary Carreon: Yeah. I mean, I don't think that they are looking at, I don't think that they are looking [00:43:00] at it the way that we are. I don't think that they can see it from their vantage point. Um, I think that like, in the, in a similar way that so many CEOs who run businesses have no fucking clue about what's actually happening in their businesses and the actual workers and, and employees of their businesses can tell them in more detail. Mary Carreon: Far more detail about what's actually happening on the, on the floor of their own business. Uh, I think that it is something like that. However, that's not to say that, you know, these, these CEOs who employ people who build the A algorithm are obviously guided to create the limitations on us as people who speak about drugs, et cetera, and are creating a algorithm that ultimately is looking at things in a very blanket way in terms of, uh, like we're probably seen on the same level as like drug dealers, if that makes sense. Mary Carreon: Which is obviously a much, you know, there's, [00:44:00] it's a very different thing. Um, so, you know, there's like these CEOs are giving directions to their employees to ultimately create systems that harm. Information flow and inform and, and like the information health of, of platforms and of just people in general. Mary Carreon: So it's hard to say because there's nuance there, obviously, but I would bet you that someone like Elon Musk doesn't really have a full grasp as to the, the nuances and details of what's even happening within, on the ground floor of his businesses. Because that's like, not how CEOs in America run, run, and operate. Mary Carreon: They're stupid companies. So, so yeah. And I feel like that, like, that's across the board, like that's across the board. That's how I, that's probably how Zuck is operating with Meta and Facebook, et cetera. And yeah, just likewise and across, across the whole, [00:45:00] across the whole spectrum. Joe Moore: Mm-hmm. Yeah. And I think, um, a thing. Joe Moore: Then as the people like, we need to keep looking at how can we keep each other informed. And that's kind of circling back to drug journalism like we do and like, um, other, other sorts of journalism that doesn't really get the press it deserves. Right. And I've been getting far more content that I find more valuable off of tragically back on Zucks platform like IG is getting me so much interesting content from around the world that no major outlet's covering. Mary Carreon: That's so interesting. Like what? Like what would you say? Joe Moore: Oh, um, uh, certain, um, violent situations overseas. Oh, oh, got it. Yeah, yeah, yeah. And, um, you know, that America's paying for, so like, you know, I just don't love that I don't have a good, you know, journalistic source I can [00:46:00] point to, to say, hey, like right. Joe Moore: These writers with names, with addresses, like, and offices here. Yes. You know, they did the work and they're held, you know, they're ethical journalists, so yes. You can trust them. Right. You know what I mean? Yes, Mary Carreon: yes. Yeah, yeah, yeah. I mean, all of this makes everything so much harder for determining, like, the censorship specifically makes it so much harder for the people to determine like, what's real, what's not. Mary Carreon: Because, because of exactly what you just said. Mm-hmm. Like, you know, we are, we are basically what that means, like what is required of the people and people who are consuming information is becoming a smart consumer and being able to determine what's real, what's not. How can we trust this individual? Mary Carreon: How can we not, which isn't analysis process that all of us need to be sharpening every single day, especially with the advent of AI and, uh, how quickly this, this type of content is coming at all of us. Like, especially if you're on TikTok, which many of us are, you know, like information comes flying at you 3000 miles an hour, and it's sometimes [00:47:00] really difficult to determine what's real, what's not, because AI is. Mary Carreon: AI is not where it's going to be, and it still is in its nascent phase. However, it's still pretty fucking good and it's still very confusing on there. So, so again, like the media literacy of the people needs to be sharpened every single day. We cannot be on there, we cannot be on the internet existing. Mary Carreon: That everything that we are seeing is real. Whether that's about, you know, these, um, the violence overseas, uh, happening at the hands of the United States, whether that is, uh, even drug information like, you know, et cetera, all of all of it. Or just like news about something happening at Yellowstone National Park or something that is happening in the, uh, at like. Mary Carreon: Um, like potential riots also happening at protests in downtown la, et cetera. Like all, all of it, we need to be so careful. And I think what that also, like, one way that [00:48:00] we can adjust and begin to develop our media literacy skills is talking to people maybe who are there, reaching out to people who are saying that they were there and asking them questions, and also sussing that out. Mary Carreon: You know, obviously we can't do that for all situations, but definitely some of them. Joe Moore: Yeah, absolutely. Like, Joe Moore: um, a quick pivot. Mm-hmm. Were you at PS 25? Mary Carreon: Yes, I was. What did I think? Uh, you know, I, I was running around like crazy at this one. I felt like I didn't even have a second to breathe and I feel like I didn't even have a second to really see anybody. I was like, worry. I was jumping from one stage to the next. Mary Carreon: However, I would say, uh, one of, one of the things that I have said and how I felt about it was that I felt that this, this event was smaller than it was two years ago. And I preferred that I preferred the reduction in size just because it was, uh, less over, less overwhelming [00:49:00] in an, in an already very overwhelming event. Mary Carreon: Um, but I thought that from the panels that I did see that everyone did a really great job. I thought that maps, you know, it's impressive that maps can put on an event like that. Um, I also was very cognizant that the suits were there in full effect and, uh, you know, but that's not unusual. That's how it was last time as well. Mary Carreon: And, um, I felt that there was Mary Carreon: a, uh, like the, the, the level of excitement and the level of like opportunity and pro, like the prosperous. The like, prospect of prosperity coming down the pipeline like tomorrow, you know, kind of vibe was different than last time. Mm-hmm. Which that was very present at the one, two years ago, uh, which was the last PS psychedelic science. Mary Carreon: Yeah. Um, anyways. Yeah. But it was, you know, it was really nice to see everybody. [00:50:00] I feel like in-person events is a great way for everybody in the psychedelic space to be interacting with each other instead of like keyboard warrioring against each other, you know, uh, over the computer and over the internet. Mary Carreon: I think that, um, yeah, uh, being in person is better than being fighting each other over the internet, so, yeah. Joe Moore: Mm-hmm. People seem to be a little bit more civil in person. Mary Carreon: Exactly. Exactly. Mm-hmm. And I think that that is something that we all need to be considering more often, and also inviting people from across the aisle to your events and creating peace, because in person it's a little different than it is. Mary Carreon: When you have the opportunity to, uh, yeah, like keyboard attack someone over the internet, it's like, yeah. It's just so silly. So silly. We look like fools. Like we look like absolute idiots doing that. And you know what? I cannot sit here and say that I haven't looked like an idiot. So, you know, it's like I'm not, I'm not talking from like a high horse over here, but, but you know, it's like, it's [00:51:00] better when it's in person. Mary Carreon: I feel like there's like more civil engagements that we can all have. Joe Moore: It's practice, you know? Yeah. We're learning. Yeah. We are. We should be learning, including us, and yes, of course. Um, I, I play a subtler game these days and, uh, you know, I, I, I, it's better when we all look a lot better in my opinion, because yes, we can inform policy decisions, we can be the ones helping inform really important things about how these things should get implemented and absolutely right. Joe Moore: Like, Mary Carreon: absolutely. Yeah, it does. It does. Nobody, any service, especially these medicines, especially these sacraments, especially these plants, these molecules, et cetera, if we are all sitting here fighting each other and like calling each other names and trying to dunk on one another, when like in reality, we are also all kind of pushing for the same thing more or less. Joe Moore: Mm-hmm. So a thing that [00:52:00] I, it's a, it's kind of a, I, I had a great time at PS 25. I have no, no real complaints. I just wish I had more time. Yeah, same. Um, same. Yeah. Our booth was so busy. It was so fun. Just good. And it was like, good. I, I know. It was really good. I'm trying to say it out loud. I get to talk at the conference before Rick did. laughs: Oh, oh, Joe Moore: the morning show they put us on at like seven 30 in the morning or something crazy. Oh my god. It was early. I dunno if it was seven 30. Mary Carreon: That's so early. That's so early. Joe Moore: Yeah, right. Like that's crazy. I got zero nightlife in That's okay. Um, I was not, I was there for work. Yeah, Mary Carreon: yeah. I was Joe Moore: jealous. I didn't party, but you know, whatever. Joe Moore: Yeah, yeah. Mary Carreon: I did not party this time really in the same way that I did at PS 20. Was it 2023? Joe Moore: 23, yeah. 23. I only stay up till 11 one night in 23. Nice. Mary Carreon: Okay. Um, okay. Joe Moore: So I behaved, I have a pattern of behaving. 'cause I like That's good. I'm so bent outta shape inside going into these things. I'm like, I know, I know. Joe Moore: And, and I'm like, oh, all [00:53:00] my friends are gonna be there. It's gonna be great. And then it's like, yeah. It's mostly friends and only a little bit of stress. Yeah. Um, yeah. Yeah, Mary Carreon: yeah. I had a, I had a great time. It was really good seeing everybody again. Like you, I wish that I had more time with people. Like there are people that I like didn't even see who are my friends, Joe Moore: so, which Yeah. Joe Moore: Which is sad. That's like a subtext in, in like the notes coming away from 25. Is that the, um, American Right, if we wanna call it that, is very interested in this stuff. Oh yeah. Like the Texas establishment. Oh yeah. Um, the Texas contingent, right? They're deep. They're real deep. Mm-hmm. I have, um, Mary Carreon: let's talk about that more. Mary Carreon: Yeah. So Joe Moore: it's optimistic in, in some sense that psychedelic science is getting funded more. By states. 'cause the feds aren't stepping up. Right. I love that. Right. Yeah. Like, Hey feds, look what we can do. And you can't somehow, and [00:54:00] then, um, we'll see if state rights stays around for a while longer, maybe, maybe not. Joe Moore: And then the other part is like, is there a slippery slope given the rhetoric around addiction and the rise in interest in iboga for compulsory addiction treatment with psychedelics or, or compulsory mental health treatments with psychedelics because of the recent, it's illegal to be a person without housing. Joe Moore: Um, and you're gonna get put in treatment. Mm. Like, that's now a thing. So like, I don't know, I don't think forced treatment's good at all. I, and I don't think like, um, like the data is something like 15% effective, maybe less. Right. Right. It's not a good use of money. I don't know. We're, let's, I. You can go there if you want, and riff on that, or if you wanna talk about like, Texas, um, Arizona more generally. Mary Carreon: Yeah. I mean, I will just say this, I also don't really believe that forced treatment is like good, you [00:55:00] know, data Joe Moore: says it's bad. Mary Carreon: Yeah. Yeah. I also, yeah, I mean, it's like, I don't know. Yeah, that's, it's complex. It's a complex issue. I also don't think it's good, but I also do think that we need a much better framework and foundation for like, if people do want the help, helping them get it. Mary Carreon: Much more easily and in a way that's going to be beneficial for them. Um, and I don't think that that system or that pathway currently exists as we saw in, uh, with, with, um, measure 1 0 9 and the failure of measure 1 0 9 or, or was it Measure 1 0 10, 1 10, measure one 10 in Oregon. Joe Moore: But did you see the response yesterday or two days ago? Joe Moore: No, I didn't. No, I didn't. I'll I'll send it to you later. Okay. So the university did the research, um, Portland State University did the research Yes. And said, Hey, look, there was actually 20 other things that were higher priority. Like that actually influenced this increase in overdoses, not our law. Mary Carreon: Right. Mary Carreon: Yes. It was really COVID for Okay. [00:56:00] Like for, yeah. Right. Absolutely. Also, there was not a. Like there was not a framework in place that allowed people to get off the street should they want to, or you know, like, like you just can't really have a, all drugs are legal, or small amounts of drugs are legal without also offering or creating a structure for people to get help. Mary Carreon: That, that's, you can't do one without the other. Unfortunately. That's just like a, that's faulty from the start. So that's all I'll really say about that. And I don't think that that had fully been implemented yet, even though it was something that wasn't ideal for the, um, for the, for the measure. And I believe it was measure one 10, not measure 1 0 9, to be clear. Mary Carreon: Measure one 10. Um, yes, but confirmed one 10 confirmed one 10, yes. Mm-hmm. Um, but yeah, uh, that's, you know, that's kind of what I'll say. That's what I'll, that's where I'll leave that portion. Mm-hmm. You know? Uh, but yeah, forced treatment. I don't know. [00:57:00] We can't be forcing, forcing people to do stuff like that. Mary Carreon: I don't know. It's not gonna, it's, yeah, it doesn't seem Joe Moore: very humane. Mary Carreon: Yeah. No. And it also probably isn't gonna work, so, Joe Moore: right. Like, if we're being conservative with money, like, I like tote, like to put on Republican boots once in a while and say like, what does this feel like? And then say like, okay, if we're trying to spend money smartly, like where do we actually get where we want to be? Joe Moore: And then sometimes I put on my cross and I'm like, okay, if I'm trying to be Christian, like where is the most, like, what is the most Christian behavior here in terms of like, what would the, you know, buddy Jesus want to do? And I'm just like, okay, cool. Like, that doesn't seem right. Like those things don't seem to align. Joe Moore: And when we can find like compassionate and efficient things, like isn't that the path? Um, Mary Carreon: compassionate and t. Yeah, even, I don't know, I don't know if it looks lefty these days, but Yeah, I know what you mean. Yeah, I know what you mean. I know what you mean. Yeah. [00:58:00] Yeah. Um, yeah, it's complicated. It's complicated, you know, but going back, kind of, kind of pivoting and going back to what you were talking about in regards to the subtext, some of the subtext of like, you know, where psychedelic medicine is currently getting its most funding. Mary Carreon: You know, I do believe that that was an undercurrent at psychedelic science. It was the, the iboga conversation. And there's, there's a lot, there's a lot happening with the Iboga conversation and the Iboga conversation and, um, I am really trying to be open to listening to everyone's messages that are currently involved in. Mary Carreon: That rise of that medicine right now? Um, obviously, yeah, we will see, we'll see how it goes. There's obviously a lot of people who believe that this is not the right move, uh, just because there's been no discussions with, uh, the Wii people of West Africa and, you know, because of [00:59:00] that, like we are not talking to the indigenous people about how we are using their medicine, um, or medicine that does like that comes from, that comes from Africa. Mary Carreon: Um, also with that, I know that there is a massive just devastating opioid crisis here that we need to do something about and drug crisis that we need to be helping with. And this medicine is something that can really, really, really help. Um, I find it absolutely fascinating that the right is the most interested party in moving all of this forward, like psychedelic medicine forward. Mary Carreon: And I, I currently have my popcorn and I am watching and I am eating it, and I am going to witness whatever goes down. Um, but I'm, I, I hope that, uh, things are moving in a way that is going to be beneficial for the people and also not completely leave behind the indigenous communities where this medicine comes from. Joe Moore: [01:00:00] Mm-hmm. Mary Carreon: We'll see how it goes. Yeah. We'll see how it goes. We'll see how it goes. It Joe Moore: would be lovely if we can figure it out. Um, I know, and I think, uh, Lucy Walker has a film coming out on Iboga. Mm. I got to see it at Aspen, um, symposium last summer, and it was really good. Mm. So I'm sure it'll be cut different, but it's so good and it tells that story. Joe Moore: Okay. Um, in a helpful way. I'm gonna, I, yeah. I always say I'm gonna do this. I'm like, if I have space, maybe I'll be able to email her and see if we can screen it in Colorado. But it's like a brilliant film. Yeah. Cool. This whole reciprocity conversation is interesting and challenging. And so challenging being one of the few countries that did not sign onto the Nagoya protocol. Joe Moore: Absolutely. We're not legally bound, you know, some countries are Mary Carreon: I know. Yes, yes, yes. So Joe Moore: we're, you know, how do we do that? How do we do that skillfully? We still haven't done it with, um, first Nations folks around their [01:01:00] substances. Um, I think mushrooms are a little flexible and account of them being global, um, from Africa to Ireland and beyond. Joe Moore: And, but you know, that's, we still want to give a nod to the people in Mexico for sure. Yeah, absolutely. Absolutely. Yeah. Um, yeah. Yeah, it's, I had some fun commentary there that I would love to flesh out someday. Uh, but yeah, it's not for today. Mary Carreon: Yeah, yeah, yeah. Um, there's, yeah, there's obviously, there's obviously a lot with the conversation of reciprocity here and, um, I know, I, I don't know. Mary Carreon: I, I, what I do know is that we need to be listening to the indigenous people, not just listening to them second, like secondhand or listening to them, uh, once we have moved something forward, like actually consulting with them as the process goes. And that, you know, the way that both parties move, indigenous folks and, uh, western folks move, uh, are at inherently different paces. Mary Carreon: And, [01:02:00] um, I just hope, and I wish, and I, I hope, I just hope that, uh, Western what, like the Western party, the western folks who are diving into these medicines. Slow the fuck down and listen and just are able to at least make one right move. Just one, just like you. Like it's, doesn't have to be this, it doesn't have to be that hard. Mary Carreon: Although the pace of capitalism usually propels, uh, the western folks at, at a much quicker rate than, u

Numa semana tão especial, que antecede o prazo máximo que o STJ estipulou para que enfim sejam publicadas as diretrizes da regulação do plantio de cannabis em larga escala no Brasil, eu conversei com a Corina Silva, empresária com vasta experiência em processos regulatórios da planta para falar sobre os erros, os acertos e as oportunidades (muitas vezes, perdidas) de todo esse processo no Brasil.A matriarca, que junto à sua família, fundou e dirige a USA Hemp, uma multinacional canábica bem consolidada, compartilha experiências que viveu na regulação norte-americana, contextualiza e analisa o cenário brasileiro e crava que deixar de fora da regulação os aspectos industriais da planta é um dos maiores equívocos que o governo pode cometer, se a coisa seguir para onde parece que tá indo.Aperta o play para saber por que regular só o medicinal é um tiro no pé!***Encontre a Corinano Linkedinhttps://www.linkedin.com/in/corina-silva-5a2a27358/no Instagramhttps://www.instagram.com/corinasilvaphotography/Encontre a USA Hemp, USA Hemp Academy e a Fundação Redwoodusahempbrasil.com.brhttps://www.instagram.com/brasilusahemp/https://usahemp.academy/https://rw.foundation/***Corina indicaAs mulheres incríveis da EmbrapaDaniela Bittencourt - https://www.linkedin.com/in/daniela-bittencourt-a4899a55/Beatriz Emygdio - https://www.linkedin.com/in/beatriz-marti-emygdio-344952324/***Compre a sua edição impressa da edição de 50 anos da High Times, com reportagem da Anita Krepp: https://shop.hightimes.com/products/high-times-magaine-50th-anniversary-issue***MARCAS APOIADORAS DA 4ª TEMPORADAUnyleya: http://unyleya.link/anitakreppUSA Hemp: https://www.usahempbrasil.com/Flora Urbana: https://floraurbana420.com.br/Blis: https://appblis.com.br/aLeda: https://www.instagram.com/aledaoficial/***Essas são marcas que reconhecem o valor da comunicação responsável e do jornalismo de qualidade no processo de desestigmatização da planta, promovendo informação para a normalização do que um dia foi tabu.***Para seguir por dentro dos avanços da cannabis e dos psicodélicosAssine a news: https://cannabishoje.substack.com/Siga no Insta: https://www.instagram.com/cannabishoje/Se inscreva no Youtube: https://www.youtube.com/@cannabishojeAcesse: https://cannabishoje.com.br/

Aesha Waks reflects on her childhood struggles and her quest for inclusion as a young actor in the industry. She shares experiences like walking the runway at Madison Square Garden and Lincoln Center, appearing in makeup campaigns and bus ads, and gracing the covers of High Times and Playboy alongside Paris Hilton, where she mingled with Hugh Hefner. She now cares less about others' opinions and is focused on owning her own path.You can connect with Aesha Waks on Instagram @aeshahashwaks

Send us a textIt's a backyard chat with our sponsor. Founder and CEO of Black Tie, Kyle Colpack hangs out for a toke. We talk Black Tie, Giveaways, High Times and more! To get your hands on award winning cannabis from Black Tiehttps://blacktiecbd.net/?ref=highstickingUse promo code highsticking to receive 20% off of your purchaseMust be 21 to purchase.

For much of 2025, the livestock sector has been one of the few areas of agriculture enjoying strong commodity prices and strong returns, but there are some challenges the industry needs to overcome. NAFB News ServiceSee omnystudio.com/listener for privacy information.

When a bunch of vulture capital d-bags ran High Times into bankruptcy, the magazine's illustrious fifty year history appeared to be burnt out. But then, in June, Raw Papers founder Josh Kesselman announced that he'd bought the brand for $3.5 million. In this episode, Josh explains how and why he bought High Times, and his high hopes for a return to glory. Josh also shares his own weedy life journey, an inspiring tale of a young stoner who became obsessed with rolling papers, opened a bootstrapped headshop while still a college student, and eventually created an iconic global weed brand of his own.  PATREON Please ⁠⁠⁠⁠⁠⁠support Great Moments in Weed HIstory on Patreon⁠⁠⁠⁠⁠⁠. Supporters get exclusive access to video versions of this podcast and private seshes, plus cool rewards like a signed book. And it truly helps us make the best show possible. EPISODE ARCHIVE Visit our podcast feed for 150+ episodes of Great Moments in Weed History, and subscribe now to get a new weekly podcast every Weednesday.

Stoney Tark is a prolific writer based in Europe who is known for his articles about cultivation, breeding, hash making, interviews, and especially his top tips. Over the last 11 years, he has become one of the most recognized writers in the cannabis industry.Stoney is or has been the head cultivation writer for various magazines, including Soft Secrets, High Times, Skunk, Garden Culture, Weed World, The Emerald, Cannabis Culture, Dutch Passion, The Super Sativa Seed Club, Paradise Seeds, Humboldt Seed Organization, Atami, and ILGM. Stoney is also a breeder for Prana Medical Seeds, sponsored by SANlight, and he is the author of Stoney Tark's Top Tips on Growing Cannabis available on Amazon. Stoney Tark is a producer of the YouTube channel The Roll Models Podcast.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

PJ Olsson is currently the lead singer for the Alan Parsons Live Project. He has five released albums. He has toured with various artists over his lifetime, including Kid Rock, Muse, Train, Rufus Wainwright, Iggy Pop, Beth Orton, Bob Geldof, Ben Harper, Nelly Furtado, Placebo, Michelle Branch, and others. Olsson also produces and writes for other artists and writes songs for movies, TV, and advertising. PLEASE WELCOME Musician, singer, songwriter, producer, composer, and Grammy award winner (Engineer) P.J. Olsson to Interviewing the Legends.     FOR MORE INFORMATION ABOUT P.J.OLSSON VISIT https://pjsrockcamp.wordpress.com/whatisrockcamp/ PJ's Rock Camp Official Website https://www.facebook.com/pjsrockcamp/ PJ's Rock Camp on Facebook https://x.com/pjsrockcamp Rock Camp on Twitter https://alanparsons.com/ Alan Parsons official website https://www.facebook.com/alanparsons Alan Parsons Facebook   Career Highlights Grammy Award for Best Immersive Audio Album, Eye In The Sky – 35th Anniversary Edition (2018 Nominated for a Grammy Award for engineering on Alan Parson's latest release A Valid Path Visine is the 1998 High Times song of the year Performed live on the David Letterman late show The Whistle Song featured in a Starburst campaign Appeared on CNN Appeared in Newsweek, Rolling Stone and USA Today magazines Music on CSI New York, CSI Miami, The Ghost Whisperer, Nip/Tuck and Dawson's Creek Tours internationally as the lead vocalist for the Alan Parsons Live Project   ALAN PARSONS LIVE PROJECT TOUR DATES  2025 08.22.25 Boston, Massachusetts On The Blue Cruise 09.13.25 Milwaukee, WI The Riverside Theater 09.14.25 Waukegan, IL Genessee Theatre 10.02.25 Bethlehem, PA Wind Creek Casino 10.03.25 Atlantic City, NJ Ovation Hall at Ocean Casino Resort 10.25.25 Cabo San Lucas, MX Cabo Sunset Festival - Medano Beach PUBLIC ON SALE JULY 11 - 10AM PST   P.J.OLSSON DISCOGRAPHY: Solo 1998: P.J. Olsson 1999: Words for Living 2005: Beautifully Insane 2007: American Scream 2013: Lasers and Trees   with Alan Parsons Studio albums 2004: A Valid Path - vocals, programming 2019: The Secret - vocals on "Years of Glory" 2022: From The New World - vocals, keyboards, programming, bass guitar Live albums 2010: Eye 2 Eye: Live in Madrid - acoustic guitar, vocals 2013: LiveSpan - vocals 2016: Alan Parsons Symphonic Project, Live in Colombia - vocals, guitar Singles 2010: All Our Yesterdays 2014: Fragile 2015: Do You Live at All   Compilation appearances 1999: Songs from Dawson's Creek (various artists) - vocals on "Ready for a Fall" Support us on PayPal!

In this episode, Liam sits down with legendary photographer and journalist Maggie St. Thomas. With a camera in hand, Maggie has spent decades capturing raw, unfiltered moments from music's most chaotic corners — from the grime of LA's underground punk scene to the haze-filled green rooms of hip hop royalty.We talk about her new book Subject: Punk, her childhood surrounded by music and mayhem, photographing the Ramones, Sublime, and yes — smuggling weed in a trench coat to photograph Snoop Dogg for High Times.Maggie also opens up about her time working in a crematorium, the emotional weight of documenting vulnerable artists, and why punk isn't just a sound — it's a way of being. Check out Maggie's work via this link

Beef continues to be the bright spot in agriculture in 2025 with record-high prices for producers, but one analyst is reminding producers that it won’t last forever. NAFB News ServiceSee omnystudio.com/listener for privacy information.

From judging the Cannabis Cup in Amsterdam, to touring Northern California during harvest season, to seshing with the steady stream of growers, dealers, breeders, smugglers, rogues, outlaws, musicians, celebrities, and activists who stopped by the High Times offices in New York City during our illustrious tenure at the mag, Danny Danko and I have shared many incredible adventures in the field.. So lets exhale the bullshit…. inhale some good shit… and jump into the hot box time machine for a heady trip back to a far more freewheeling, swashbuckling era in weed history than we find ourselves in now. And we'll also hear about Danny's new gig as cultivation section coordinator for the influential and historic Champs Trade Shows. PATREON Please ⁠⁠⁠⁠support Great Moments in Weed HIstory on Patreon⁠⁠⁠⁠. Supporters get exclusive access to video versions of this podcast and private seshes, plus cool rewards like a signed book. And it truly helps us make the best show possible. EPISODE ARCHIVE Visit our podcast feed for 150+ episodes of Great Moments in Weed History, and subscribe now to get a new weekly podcast every Weednesday.

Well, OF COURSE Elon was high the whole time! Titus Podcast... SCREAM SANITY! For Christopher Titus tour dates, specials, and merch visit: https://www.christophertitus.com/ For Rachel Bradley tour dates and merch visit: https://www.rachelbradleycomedy.com/ For The Hylinder's music and merch visit: https://www.thewillingbureau.com   To advertise on our podcast, please reach out to sales@advertisecast.com or visit https://www.advertisecast.com/ChristopherTitusPodcast

This week on We Think It's Funny, Emmy-nominated comedian and writer Mike Glazer joins Mark Schiff and Daniel Lobell for a hilarious, wide-ranging conversation you won't want to miss. From Mike's days at Second City Chicago during its iconic 50th anniversary to his work with CBS, truTV, High Times, and Rolling Stone-acclaimed live shows like Glazed, he brings stories and laughs from every corner of his career. The guys dive into everything from the early days of New York stand-up at Catch a Rising Star, to weed culture, Italian coffee cake obsessions, and plenty more —tune in and get ready to laugh.

Brad Thelen, owner of Long Prairie Livestock in Long Prairie, Minnesota, says dairy cattle continue to sell well.See omnystudio.com/listener for privacy information.

Cattle ranchers have been experiencing record high prices, but how long can it last?See omnystudio.com/listener for privacy information.

Kyle Kushman and his longtime friend, Ed Borg reflect on 30+ years of growing history and culture. They share stories from the early outlaw days, trade hard-earned cultivation wisdom, and reveal how their community grew from an underground movement to a global phenomenon. This candid conversation blends practical grower tips with colorful tales, making it a treat for both home growers and cultural enthusiasts. They reminisce about sneaking 4:20 smoke sessions in the stairwell at High Times magazine back when public herb use was totally forbidden. They also recall the legendary pilgrimages to Amsterdam for the annual Cup events – a time when a tight-knit family of pioneers would reunite under the radar for the love of the plant. Beyond the nostalgia, the discussion covers how passion for cultivation has taken them across the world. A fateful offer from a Dutch coffee shop gave one guest the chance to move to Amsterdam and pursue his dreams openly. Meanwhile, Kyle describes leaving New York for California during the early medical era, finally able to grow freely under Prop 215 after years of hiding. Fast forward to today: they're swapping notes on running a licensed farm in tropical Thailand, complete with inventive tricks like solar-powered lights to handle the short 12-hour daylight cycle! Even after decades, these veterans are still learning new tricks and staying humble. They admit that unexpected challenges can make a master grower feel like a beginner again – they've even looked up basic cloning tutorials online when things go sideways. On the flip side, they marvel at how much easier things are now compared to the old days of prohibition. Back then, you might plant four just to end up with one (accounting for thieves, pests, or the law), whereas today passionate growers can finally cultivate openly and abundantly. Through all these changes, one thing remains constant: their love for the craft (and the plant) keeps growing stronger.01:54 – Secret 4:20 Sessions07:59 – Amsterdam Life-Changing Move12:01 – Master Grower's New Challenges25:21 – Generational Growing ShiftEnjoyed the chat? Smash that like button and subscribe for more content. Don't forget to ring the bell for notifications so you never miss an episode, and drop a comment below sharing your favorite moment or any questions! Plus, be sure to follow @natehammer420 and @homegrownseed on Instagram for more awesome content and updates from our community.DisclaimerThis content is intended for educational and cultural purposes only. We do not encourage any illegal activity – always obey the laws and regulations in your area.

In this video, renowned cultivator Kyle Kushman recounts how the legendary Strawberry Cough cannabis strain came to be. From a chance discovery in a New York grow-op in the early 2000s to its rise as a staple of American cannabis culture, this strain's journey is extraordinary. Kushman recalls smelling the plant's sweet, strawberry aroma and knowing it was something special. He spread Strawberry Cough across the country, gifting clones from New York to California and sparking a nationwide cannabis phenomenon. Key Highlights05:40 - Discovery of Strawberry Cough 08:14 - “Johnny Hempseed" Journey 19:55 - Tissue Culture Revitalization of Strawberry CoughAs Strawberry Cough's popularity grew, so did rumors about its origin. Kushman sets the record straight, debunking myths and clarifying he never claimed to breed the strain — only to share it. He highlights the cannabis community's spirit of generosity, showing how sharing clones and modern techniques like tissue culture kept this beloved plant thriving for over two decades. Along the way, we learn about Kushman's role in U.S. cannabis history, from High Times magazine to winning a Cannabis Cup with Strawberry Cough, all underscoring why this strain holds iconic status in the cannabis community. Whether you're a cannabis cultivation enthusiast or just love a good origin story, this video offers a unique look into American cannabis culture and the true story behind an infamous strain. Like this video if you enjoy it, comment with your thoughts on Strawberry Cough, and subscribe for more stories and grow tips. Follow @natehammer420 and @homegrownseed on Instagram for more cannabis content and updates! Disclaimer: The views and opinions expressed in this video are for educational purposes only. The sale, purchase, or consumption of products federally outlawed is not endorsed or supported in any manner.

Become a Discourse memberEnjoy the pod? Support us with a small monthly donation on Patreon and unlock access to our exclusive Discourse community—deep dives, hot takes, and smarter sport talk await!In this week's Spotlight, we dive into the science behind an eye-watering nutrition number: 200 grams of carbohydrate per hour. That's what elite Ironman Cameron Wurf reportedly consumed during a record-breaking bike leg in Texas. But does the body actually use it all—or is there a ceiling to sugar oxidation? Ross and Gareth break down a recent study comparing 120g and 90g per hour in trained cyclists, revealing how much of that fuel actually gets burned, and whether it has the purported effects on fuel use during exercise. Before we hit the carb overload, we've got a mix of big stories from across the sporting world:

Everybody's feelin' groovy, because this week we're traveling way back to 1970 with bassist/vocalist Ron Flynt and guitarist/vocalist Steve Allen from legendary power poppers 20/20! Aside from remembering the staggering number of great records released during our year of focus, we celebrate the release of 20/20's new album Back to California, their first LP in over 25 years, out now on Spyderpop / Big Stir Records. Whether you're a newcomer to the band or an ardent fan of their classics like "Yellow Pills", "Cheri", "Remember The Lightning", and "Nuclear Boy", prepare to fall in love with the hooks n' harmonies of the new record, which hearkens back to their roots but maintains a fresh and modern sound. Plus, Steve and Ron talk about feeling the magic again, reminisce about the early days of the band, the recording of their signature track (1979's "Yellow Pills"), hanging out in Phil Spector's mansion, dancing with Linda Blair, rubbing shoulders with Hollywood stars at Sunset Strip haunts...and did O3L turn into the High Times podcast?!? Finally, we give the guys their belated induction into the Power Pop Hall of Fame...which we're in no way authorized to do, but they weren't aware they were already in it! Great stories, lots of laughs, and amazing music...turns out hindsight really is 20/20! Thanks to Rex Broome and Christina Bulbenko from Big Stir Records for the introduction. Proud members of the Pantheon Podcasts network. Learn more about your ad choices. Visit megaphone.fm/adchoices

Come along this week to hear about our Easter weekend. Also are you money motivated or satisfied with just the minimum. Come check us out.

In this conversation, Dr. Riley Kirk and Dr. Josh Kaplan delve into the complexities of cannabis research, particularly focusing on CBD and its therapeutic potential for conditions like epilepsy. Dr. Kaplan shares his journey into cannabis research, highlighting the significance of understanding CBD's mechanisms, the role of GPR55 in seizure management, and the challenges of dosing CBD effectively. They also discuss the entourage effect, the importance of personalized medicine, and the ongoing research into terpenes and their interactions with cannabinoids. The conversation emphasizes the need for further exploration in cannabis research to develop safe and effective therapies, especially for vulnerable populations like children. In this conversation, Josh Kaplan discusses the therapeutic potential of CBD, particularly in relation to traumatic brain injuries and neurodegenerative diseases. He emphasizes the safety of CBD compared to THC and explores its role in preventative treatments. The conversation also delves into ongoing clinical trials, particularly within the NFL, and the challenges faced in cannabis research, including dosing and the variability of individual responses to cannabinoids. Kaplan highlights the importance of understanding the entourage effect and the need for more personalized approaches in cannabis treatment. More about Dr. Kaplan: Dr. Kaplan is an Associate Professor in the Behavioral Neuroscience Program. His expertise is in neurophysiology, neuropharmacology, and animal behavior techniques, which his lab uses to study the therapeutic benefits and developmental consequences of cannabis in pre-clinical rodent models. His research seeks to optimize cannabinoid and terpene compositions to maximize benefit and minimize adverse consequences.  Dr. Kaplan has a strong passion for teaching and communicating science. His scientific writing specializes in the science of cannabis and its medicinal utility. He was included in High Times' 100 Most Influential People in Cannabis (2018) and Cannabis Newsletter's Top 100 (2021). Follow Dr.Kaplan's research: https://wp.wwu.edu/kaplanlab/ Preorder my book Reefer Wellness! https://www.amazon.com/Reefer-Wellness-Understanding-Cannabis-Medicine/dp/0593847156 Seed Giveaway Thank you to Royal Queen Seeds and Last Green Valley Seeds for donating to this week's giveaway! To enter, fill out the form below, winners will be selected at random.  https://forms.gle/1vWtsBMGaux9x5Mf6 ✨ Want Exclusive Content? Join the Bioactive Patreon community for as little as $1/month to ask guests your burning questions, access exclusive content, and connect with Dr. Kirk one-on-one. www.Patreon.com/Cannabichem

DNA Genetics: Unique Strains for Hash, Amsterdam Beginnings, Legacy PartnershipWhen we say that today's guests are responsible for some of the biggest strains in the history of the plant, it's almost an understatement. We all grew up in the late 90s and early 2000s hearing about the cultural boom in Amsterdam, but these guys were living it.Blackleaf is blessed in the FSOTD studio by none other than Don and Aaron aka DNA Genetics, basically your OG's OGs, to discuss their migration to Amsterdam, running with legends like Sam the Skunkman and Dave Crockett, how they began breeding seeds in the early 2000s, coming back to the US, and the natural evolution of DNA Genetics that's turned them into a global brand with more hall-of-fame hitters than you can count.For the uninitiated, DNA Genetics is a renowned breeding company founded in Amsterdam in 2004, known for creating some of the industry's most iconic and award-winning strains. Some of these legendary strains include LA Confidential, Kosher Kush, and Tangie. DNA Genetics continues to innovate and expand with a strong global reputation, influencing the market through collaborations, seed distribution, and cutting-edge breeding techniques.You'll get to hear Don and Aaron dive deep into their ex-pat lives in Amsterdam and how they got their first building locked down, immediately started blowing massive tree, and had the cops bust down their doors on day 1. They soon partnered with a local coffee shop to grow and slang their creations, eventually having locals come in asking for seeds based on fire herb they blew just down the street. If you've ever heard of the “good old days” these were definitely them. You seriously can't count the number of unbelievable stories that are contained in this pod.Some of the other crazy tidbits that pop up during this episode include the DNA Genetics x Crockett Family Farms origin story and creating Tangie, how B-Real named the 24k strain, the LA Confidential story, how the Chocolope strain got its name on accident, growing seeds from Shantibaba himself, and how they got Barrington Levy to play an unforgettable High Times party in Amsterdam back in the day.Don and Aaron are undeniably living legends in the industry that continue to partner, expand, and take over the world with their renowned genetics. Look out for their upcoming releases with Sensi Seeds through their Breeding Grounds project, a global collaborative breeding project, the likes of which include Sherbinskis, Serge, Humboldt Seed Co., and more.Subscribe to our channel and the FSOTD.com site to keep up with other key players and enjoy conversations with trailblazers from the culture you can't find anywhere else. Hosted on Acast. See acast.com/privacy for more information.

Michael Zaytsev, aka Professor Z, sits down with branding legend and bestselling author David Paleschuck to explore the evolution of cannabis marketing and what it really takes to build a brand that lasts. As the founder and CEO of Branding Bud Consulting Group, David has worked on some of the most iconic mainstream and cannabis brands. Now he's helping elevate cannabis branding through his books, teachings, and consulting. In this candid conversation, David shares lessons from his journey, the importance of knowing your customer, and insights from his upcoming book The Cannabis Brand Licensing Bible. Topics Discussed:

Ask Chad Grassy Logic S3 Ep10 - Hospitaly-THC Guest: Kaz Summary: "Hey everyone, welcome back! I'm thrilled to have Kaz back in the studio. We're catching up on everything he's been up to since his last visit, which feels like ages ago! Kaz is going to share some behind-the-scenes stories from his time with High Times, and we'll get the inside scoop on his exciting new venture, 'Best in Grass,' which is bringing a fantastic cannabis competition to New Mexico. We'll definitely be diving deep into his perspective on THC, and why it's not the only factor when it comes to quality cannabis. Plus, Kaz and I will be chatting about the crucial difference between just selling cannabis and creating a real hospitality experience in consumption lounges – something we've both seen a lot of lately. And of course, we'll get Kaz's take on the latest developments with federal cannabis legalization. Trust me, this is going to be a lively conversation with lots of insights from Kaz, so stick around!"

• Plumbing issues and appreciation for working toilets   • Joke about tossing waste off balconies   • Modern Plumbing Industries ad, services, and outdoor shower install   • Praise for Modern PI's reliability and wide service area   • Tom and Dan show intro with Ross McCoy guesting   • Tom fights off a worsening cold, uses vibrating pipe device for lungs   • Gross loogie talk and clearing chest congestion   • BDM Appreciation Week and April 19th Party details   • BDM perks, joke about drunken double sign-ups   • Hollerbach's Chef Pat 20-year event with surprise belt from Adam Pierce   • Tom's awkward speech and surprise-ruining moment   • Surprise party debate and Pat's dislike of surprises   • Praise for pork shank, Tom eats too fast   • Dinner with Norm, Crystal, Simone, Brendan O'Connor, and more   • Tom covers Norm & Crystal's meal, sparking financial tension with Dan   • Argument over voicemail service and walker re-use   • Sword cane debate and long-borrowed item disputes   • Realization that many friends have helped Tom over the years   • Christine praised for event help and gifting   • Tom wonders if he gives enough, Dan prefers self-reliance   • Favors make people feel good—Tom's German restaurant favor test   • Ross takes favors, remembers early BDM sod farm party   • Underage bartender and shirtless Ron at wild first BDM bash   • Dan rides with listener who had full-scale marijuana grow house   • High Times photo ops and weed legality vs. old paranoia   • Dan's electric Vespa project update   • Story of drug dealer with $10k pit bulls   • Ross links dog breeding to party lifestyle   • Ross's dog confused by barking truck   • Tease of “Snow Brown” story   • Wild NJ police chief antics: pranks, harassment, spiked coffee   • Discussion on toxic prank culture in police departments   • Pee pranks, courtrooms reading gross quotes, and Coke pube clarification   • New music from Laura Jane Grace, the Gamblers, Common Saints, Catbite   • Streamline Mortgage ad with Brian ZIMMO's proactive refinance approach   • Ross books comedy show in Bunnell (April 3rd) and Bull & Bush Character Night (April 23rd)   • Ram Davasy and Rue Nafasat to host   • Dan dreams of tiny-town living and Hardy's fried chicken   • Nostalgia for small-town gas stations and authentic Mexican food   • Tom's maskless pandemic visits to rural towns   • Listener voicemail about hazard light etiquette   • Legality of hazard light use while pulling over   • Parking signal confusion and hazard etiquette on modern vehicles   • Tom's parking chaos vs. Crystal's precision   • Ross likens Tom's methods to AI-generated logos   • Tommy inherits Tom's improvisational style, forgets backpack   • Camping trip responsibilities, overcommitting, and scheduling regrets   • Ross's challenge to Tom: pallet truck test with no training   • Dan and Grizz used to ride pallet jacks at Home Depot   • Listener Clark vents about school pickup lines   • Andrea parks and walks, while others arrive hours early   • Ross's pickup line S-curve and blocked traffic complaints   • Schools assign traffic staff due to parental incompetence   • Precision vs. chaos in school release systems   • Tom's mom warned to stay quiet about drug dealer at bus loop   • Listener story bluffing cop out of car search with weed   • Tactics when dealing with police smell-based searches   • Dan's joke about hops as weed smell decoy   • Listener Neal mentions Dan's “Who's the Baddie?” Coco episode   • “Space Pups” vs. “Space Buddies” and fart jokes in dog movies   • Nostalgia for early radio work and morning show indifference   • Dan learns not to over-prepare for radio   • Akeem Woods fired for giving away food and talking too much   • Critique of corporate promotions and performance disconnect   • Mockery of corporate “family” language and blind loyalty   • Daniel enjoys doing quality work for the work's sake   • Biggest raise came during a low-effort year   • Andrea praised for effort vs. reward balance   • Listener calls in about racism at hibachi restaurants   • Cruise ship chefs vs. stereotypical performances   • Satirical take on restaurant stereotypes   • New music: Common Saints – “Firebird”   • Dan's comfort food from Current Seafood Counter   • The Orb: chaotic Van family bad luck   • Jennifer joins to describe I-4 trailer fire during band haul   • Jen extinguishes fire with Sunkist, faces mechanical doubts   • Praise for Jen's competence and responsibility overload   • Jen drops trailer in Daytona, sets up floor solo   • Becca places 6th after only 5 months of training   • Flags possibly burned from Jen's roadside cigarette   • Dan emotional about hardworking kids in extracurriculars   • “Explosion of the Month” segment: 1970 Oregon sperm whale   • Whale explosion aftermath and alternative disposal ideas   • Exploding Whale Day and papier-mâché firework whale plans   • ChatGPT joke frustrates Dan, idea to book it as comic   • Debate on AI-written stand-up vs. original material   • Comedians' delivery vs. content—Preacher Lawson, Mitch Hedberg   • “Yesterday” film premise, stand-up theft parallels   • Heather Shaw's Jim Carrey impressions and style impact   • Corey Feldman on Billy Corgan's podcast—chaotic persona   • Booking Corey for BDM party? $15k and tolerability concerns   • Podcast ambush idea for Corey Feldman   • Ross plugs “The Orlando Talk Show” with therapy guests   • Pints and Paws event details and pet charity support   • Joke about local dealer getting charity cut   • New BDM merch drop and email reminders for party   • Final show thoughts on work/life balance and fulfillment   • Show ends with “Ram Daisy” sign-off ### **Social Media:**   [Website](https://tomanddan.com/) | [Twitter](https://twitter.com/tomanddanlive) | [Facebook](https://facebook.com/amediocretime) | [Instagram](https://instagram.com/tomanddanlive) **Where to Find the Show:**   [Apple Podcasts](https://podcasts.apple.com/us/podcast/a-mediocre-time/id334142682) | [Google Podcasts](https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL2FtZWRpb2NyZXRpbWUvcG9kY2FzdC54bWw) | [TuneIn](https://tunein.com/podcasts/Comedy/A-Mediocre-Time-p364156/) **The Tom & Dan Radio Show on Real Radio 104.1:**   [Apple Podcasts](https://podcasts.apple.com/us/podcast/a-corporate-time/id975258990) | [Google Podcasts](https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkLnBvZGJlYW4uY29tL2Fjb3Jwb3JhdGV0aW1lL3BvZGNhc3QueG1s) | [TuneIn](https://tunein.com/podcasts/Comedy/A-Corporate-Time-p1038501/) **Exclusive Content:** [Join BDM](https://tomanddan.com/registration) **Merch:** [Shop Tom & Dan](https://tomanddan.myshopify.com/)

Ever felt like your body just won't respond, no matter how much you try? You're not broken—but the way we've been taught to think about female pleasure is. In this episode, we explore why orgasms can feel impossible for some women and how cannabis is now being recognized as a legitimate medical treatment for female orgasm difficulty (FOD). Some U.S. states, including Illinois and Connecticut, have even added FOD to their list of qualifying conditions for medical cannabis! If you've ever felt frustrated, pressured, or ashamed about your orgasms (or lack thereof), this episode will change everything you thought you knew about your body and pleasure.     More from Our Guest:

Whether rolling up a six-paper-joint or hiding their hashish by making it into a driveway, the Trailer Park Boys have been growing, smoking, and celebrating the herb on their hit TV series for more than 25 years. So when GMIWH sat down with Robb Wells (who plays Ricky), there were more incredible weed stories to share than Randy eats cheeseburgers. So roll up and settle in for the behind-the-scenes origin story of one of the funniest and most heartfelt shows of all time. And as a bonus, your host shares a few TPB stories too, from the time Bean played "Greasy Stoner #1" in an episode, to getting the boys on the cover of High Times, to going to a wrap party held right in the heart of Sunnyvale Trailer Park—one of the most mythical realms in all of Stonerdome. Grow Your Own: If you want to keep the vibes high, you can acquire some Ricky's Hash Plant seeds from their suppliers at Brothers Grimm Seeds. PATREON Please support Great Moments in Weed HIstory on Patreon. Supporters get exclusive access to video versions of this podcast and private seshes, plus cool rewards like a signed book. And it truly helps us make the best show possible. EPISODE ARCHIVE Visit our podcast feed for 150+ episodes of Great Moments in Weed History, and subscribe now to get a new weekly podcast every Weednesday.

Sean Howe - Thomas King Forçade - AGENTS OF CHAOS - High Times & the Paranoid End of the 1970sSep 27, 2023Sean Howe joins Ed Opperman to discuss his book, Agents of Chaos, which focusses in on the legendary iconic, revolutionary publication High Times.The life and times of High Times'  enigmatic founder Thomas King Forçade, an underground newspaper editor  and marijuana kingpin who—between police raids, smuggling runs, and  outrageous stunts—battled both the US government and fellow radicals.At  the end of the 1960s, the mysterious Tom Forçade suddenly appeared,  insinuating himself into the top echelons of countercultural politics  and assuming control of the Underground Press Syndicate, a coalition of  newspapers across the country. Weathering government surveillance and  harassment, he embarked on a landmark court battle to obtain White House  press credentials. But his audacious exploits—pieing Congressional  panelists, stealing presidential portraits, and picking fights with  other activists—led to accusations that he was an agent provocateur.As  the era of protest faded and the dark shadows of Watergate spread,  Forçade hoped that marijuana could be the path to cultural and economic  revolution. Bankrolled by drug-dealing profits, High Times would be the Playboy of pot, dragging a once-taboo subject into the mainstream. The magazine  was a travelogue of globe-trotting adventure, a wellspring of news  about “the business,” and an overnight success. But High Times soon threatened to become nothing more than the “hip capitalism”  Forçade had railed against for so long, and he felt his enemies closing  in.Assembled from exclusive interviews, archived correspondences, and declassified documents, Agents of Chaos is a tale of attacks on journalism, disinformation campaigns,  governmental secrecy, corporatism, and political factionalism. Its  triumphs and tragedies mirror the cultural transformations of 1970s  America, wrought by forces that continue to clash in the spaces between  activism and power.------------------Sean Howe is an American journalist and writer. He  is a former editor at Entertainment Weekly and The Criterion Collection.  In 2012, he published the book Marvel Comics: The Untold Story, after  interviewing more than 150 people who worked at or were associated with  Marvel Comics. You can meet Sean Howe in person next week. Details: Seanhowe.com Book : Thomas King Forçade Marvel ComicsOct 2nd LA 7pm Storeys Book and Cafe (1716 W Sunset Blvd, Los Angeles, CA 90026-3225)oct 6th Changing hands Bookstore Pheonix (300 W Camelback Rd, Phoenix, AZ 85013-2384)Oct 10 Diamond Hollow Books, New York (72 MAIN STREET ANDES, NY, U.S.A. 13731)Become a supporter of this podcast: https://www.spreaker.com/podcast/the-opperman-report--1198501/support.

Stephen Chew of Samford University and Ken Keith, retired from University of San Diego, talk with Dave about factors that go into the decision to retire, what makes a for a healthy department based on their experience as department chairs, and how our teaching has evolved over the years. A theme that emerges is creating environments to support student learning. Ken and Stephen also offer some advice to early career faculty.

3rd Gen Family: Zkittlez Story, Iconic Terps, Ego Clash Tradition, Breeding WinnersIf you've ever wondered what it would've been like to be a teenager during the height of Prop 215, living in the Emerald Triangle running and gunning with legends like Jack Herer and Eddy Lepp, you can't miss a minute of the conversation with this guest.Blackleaf is joined in the studio by none other than Brandon of 3rd Gen Family Farms, Terp Hogz, Moonshine Melts, Dying Breed Seeds, and more to discuss growing up in the right place at the right time in terms of the evolution of the culture, the legend and legacies of Gas Station Bob, Overall Dave, and OGCookieMonster415, as well as his take on the creation of Original Z, the events that led to creating Ego Clash, arguably the world's premier hash competition, and where the market is currently at with predictions of the future.Brandon is not only one of the most outspoken guests we've ever had, but he is also one of the fortunate few who grew up around and learned firsthand from a lot of the legends we worship today. Originally born in LA, Brandon will unravel the story of his journey back to NorCal to his family's roots, to become a 3rd generation legacy farmer, with his mom first connecting him to Eddy Lepp and Jack Herer who lived down the street.You'll hear Brandon recall helping Eddy and Jack run their medical programs, selling whole plants to patients after they tied red ribbons around them back in veg, even advertising in the back of High Times magazine. You know, the good times.The real lore that comes to life in this pod is that of Gas Station Bob. Many have heard of this mythical figure responsible for world-famous varieties like Original Z and Rozé. Brandon dives deep into who this man is, his contributions to cultivation and breeding, and how strongly he wants nothing to do with the public eye. Among the rambunctious recollections of his past, Brandon also highlights his stake in hash making. Back when the game was rife with nothing but BHO hounds, Brandon was pushing solventless like a madman, even sweeping cups (much to the dismay of others.) He will also explain his stance on the origins of Original Z, how he believes it's a descendant of Key Lime Pie, and how he's able to visually identify real Z off the rip, and that many stopped competing in competitions once he stepped in. These events led him to create Ego Clash, the world's biggest hash competition that takes place in California and Barcelona.Crazy stories aside, Brandon lets loose a slurry of bold claims in this podcast, such as the assertion that he created Runtz, the medical vibes are dead, and if he had taken over one of Connected's early facilities there'd be no Alien Labs, and that a price surge in packs is coming, and he needs to be the one to form a high council of industry leaders to standardize quality and pricing.Love him or hate him, Brandon from 3rd Gen Family Farms is a “lifer” in this industry who's earned his legendary status over and over again, even selling untrimmed pounds of Z to Berner for $4k once upon a time. If you're a true fan of the industry and stories surrounding the plant, you will either be in stitches or on the edge of your seat for this entire episode. Tune in and try not to get your feelings hurt!Subscribe to our channel and the FSOTD.com site to keep up with other key players and enjoy conversations with trailblazers from the culture you can't find anywhere else. Hosted on Acast. See acast.com/privacy for more information.

Mark Groubert, the self-defined Forrest Gump of pop-culture has lived through more events than a dozen folks have in their lifetimes. He's an investigative reporter/features writer for the LA Weekly and was editor of The Weekly World News in 2002. He's also written for Penthouse Magazine, High Times, LA City Beat, and many other publications. From 1994 to 2001 Groubert penned more than ten screenplays including The Recruit (2003), starring Colin Farrell and Al Pacino, and served as a script doctor on dozens of others. We are honored to have him join Jackman Radio for a chat about all things JFK, history, Trump's efforts to release all files and much more! Follow Mark on X: https://x.com/lordbuckly Subscribe to America's Untold Stories:    / @americasuntoldstories   Follow Jackman Radio on X: https://x.com/JackmanRadio Become a monthly patron:   / jackmanradio   

Text Theshortdesk PodcastEp. 196!:54- We jump into a Valentine's day discussion about the crazies things we have done on that day and why do men have a problem accepting gifts on V-day?34:00- Darrell's Question of the day.39:08- We jump into news with a follow up on the 50 cent story form last weeks episode, Jay-Z getting his rape charges dropped, Drake back with a new album and Ronald Isley saying he likes listening to his music while making love. 56:58- One has to go New York Rappers edition1:04:45- What are we doing award1:05:33- Sports with Dwayne as we discuss the NBA all star weekend problemSONG OF THE WEEKRonnie Keith: Drake and Party Next Door- Gimme A HugDwayne: Torey Lanez ft T-pain- Jerry SprungerDarrell: 2 chainz and Larry June- Life is beautifulEMAIL: Theshortdeskpodcast@gmail.comFB/IG: Theshortdesk PodcastTwitter: TheshortdeskUse my special link https://zen.ai/uQkFLEY_TedWNfNOZoR4bPR4j1xUVxkRPi0SuDovOcA to save 20% off your first month of any Zencastr paid planCreate your podcast today! #madeonzencastr https://zencastr.com/?via=ronald

Ask Flora Funga Podcast anything OR Leave a ReviewDennis Walker is a journalist, podcaster and puppeteer who is primarily known for his satirizing of the psychedelic space. He is the founder and host of the Mycopreneur Podcast, with which he has published over 200 interviews platforming mushroom entrepreneurs from over 40 countries on 6 continents. Walker has been featured in Rolling Stone, Forbes, Wired, High Times, and many other international outlets.All resources mentioned on website:Wear FFP merch to support the show and impress your friends & family Zbiotics: "FLORA10"Drink ZBiotics before drinking alcohol-Alcohol produces acetaldehyde, a byproduct that your next daySupport the show***I am an affiliate with ENERGYBITS (your daily algae tablet packed with nutrients) go visit this link and use code FLORAFUNGA at checkout for 20% off***Get 20% off Sovereignty use code "KK20" Zbiotics: "FLORA10"Drink ZBiotics before drinking alcohol-Alcohol produces acetaldehyde, a byproduct that your next day SUPPORT THE SHOW: Join my Patreon for only $1/month [THATS only .03 cents a day!]Follow my other social media sites to interact and engage with me:Email me to be on the podcast or inperson Interview: floraandfungapodcast@gmail.com FacebookInstagramTwitterTikTokYouTubePatreon Help support my plant buying habit by "Buying me a Plant"a twist on buy me a coffee

Kick back and join us for another laid-back sesh where we share laughs, chill vibes, and all the fun things that come with cannabis culture. Whether you're sparking up or just hanging out, this episode is the perfect companion for your next sesh. Relax, enjoy, and let's vibe! Check out Cannabis School Approved Support the Show: Help us keep sharing cannabis education! ⁠Buy us a coffee here⁠. Connect with Us: Have questions or feedback? Reach out to us at ⁠hosts@cannabisschool.us Subscribe to our ⁠YouTube channel⁠  Follow Us: ⁠Website⁠ | ⁠Instagram⁠ | ⁠Facebook⁠ | ⁠TikTok⁠ Music Credit: Psalm Trees, James Berkeley - Ah Yeah ⁠Listen Here⁠ Cannabis education, Cannabis podcast, Cannabis enthusiasts,  sweet cannabis strains, Cannabis effects, Cannabis usage, Cannabis consumption, Cannabis strains, Cannabis tips, Cannabis wellness, Cannabis and relaxation, Cannabis and creativity, fruity cannabis strains, Cannabis community.

Whether you’re 20.5 or 50, if you love pot then High Times was the magazine for you. With ton of photos of marijuana, tips for how to grow it yourself, and other illegal stuff, High Times hung in there long enough to go from outlaw to mainstream.See omnystudio.com/listener for privacy information.

Episode 03: Dennis Walker - Satire, Mushrooms and More No one else in today's psychedelic community brings satire and useful information quite like Dennis Walker, the founder of Mycropreneur. This interview dives into many twists and turns around content, growing trends, the ever expanding mycology industry and other hot topics within today's psychedelic world. Dennis's humour and intelliegence is first rate and is worth getting to know.  Dennis is the founder of Mycropreneur a globally acclaimed mushroom media platform & mushroom startup accelerator. Featured in Rolling Stone, Forbes, Wired, Vice, High Times, etc., 25 million + video views, international conference keynotes, 100% bootstrapped.  Mycopreneur is a global community of mushroom entrepreneurs, activists and enthusiasts who are shaping the future with a little help from our fungi friends.